Level Chart

Basic Info

Boston Scientific Corp (BSX) - MedSurg Organic Revenue Growth is at 7.70%, compared to 7.60% last quarter and 9.40% last year. This is lower than the long term average of 8.60%.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 7.70%
Latest Period Sep 2024
Last Updated Oct 31 2024, 08:51 EDT
Next Release Jan 31 2025, 08:30 EST (E)
Long Term Average 8.60%
Average Growth Rate -95.53%
Value from Last Quarter 7.60%
Change from Last Quarter 1.32%
Value from 1 Year Ago 9.40%
Change from 1 Year Ago -18.09%
Frequency Quarterly
Unit Percent
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
September 30, 2024 7.70%
June 30, 2024 7.60%
March 31, 2024 7.80%
December 31, 2023 8.90%
September 30, 2023 9.40%
June 30, 2023 8.80%
March 31, 2023 13.40%
December 31, 2022 8.50%
September 30, 2022 9.80%
June 30, 2022 4.80%
Date Value
March 31, 2022 8.00%
December 31, 2021 9.40%
September 30, 2021 9.40%
June 30, 2021 67.20%
March 31, 2021 7.90%
December 31, 2020 1.10%
September 30, 2020 -1.90%
June 30, 2020 -28.40%
March 31, 2020 2.10%
December 31, 2019 10.60%

Basic Info

Boston Scientific Corp (BSX) - MedSurg Organic Revenue Growth is at 7.70%, compared to 7.60% last quarter and 9.40% last year. This is lower than the long term average of 8.60%.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 7.70%
Latest Period Sep 2024
Last Updated Oct 31 2024, 08:51 EDT
Next Release Jan 31 2025, 08:30 EST (E)
Long Term Average 8.60%
Average Growth Rate -95.53%
Value from Last Quarter 7.60%
Change from Last Quarter 1.32%
Value from 1 Year Ago 9.40%
Change from 1 Year Ago -18.09%
Frequency Quarterly
Unit Percent
Adjustment N/A

Related Securities

Symbol Name Change %
BSX Boston Scientific Corp 1.48%